Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ehrly, A.M. | Fuchs, H.
Affiliations: Division of Angiology, Department of Internal Medicine, J.-W.-Goethe-University Medical School, 6000 Frankfurt 70, Federal Republic of Germany
Note: [] Accepted by: Editor H. Hartert
Abstract: In healthy volunteers and patients with severe chronic occlusive arterial diseases, Urokinase was given intravenously. There is a dose dependend decrease in fibrinogen concentration, whole blood viscosity, plasma viscosity and red cell aggregability whereas red cell filtrability remains unchanged. This influence of Urokinase on the flow properties of blood could be responsible for some clinical improvements in patients with vascular disorders even when a thrombolytic effect is not yet detectable. Long term systemic low dose Urokinase treatment could be a promising approach in severe stages of ischemic diseases.
Keywords: Low dose Urokinase, blood viscosity, erythrocyte aggregation
DOI: 10.3233/CH-1987-7501
Journal: Clinical Hemorheology and Microcirculation, vol. 7, no. 5, pp. 665-669, 1987
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl